Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade

Background: Improving patients’ quality of life (QoL) is a principal objective of all treatment in any clinical setting, including oncology practices. Cancer-associated inflammation is implicated in disease progression and worsening of patients’ QoL. Conventional anticancer therapeutics while select...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wen-Chien, Kuo, Kuang-Tai, Bamodu, Oluwaseun Adebayo, Lin, Yen-Kuang, Wang, Chun-Hua, Lee, Kang-Yun, Wang, Liang-Shun, Yeh, Chi-Tai, Tsai, Jo-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721312/
https://www.ncbi.nlm.nih.gov/pubmed/31349728
http://dx.doi.org/10.3390/cancers11081054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721312/
https://www.ncbi.nlm.nih.gov/pubmed/31349728
http://dx.doi.org/10.3390/cancers11081054

Ejemplares similares